Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |